‘Breakthrough’ lung cancer drug made available on NHS
Tagrisso, (Osimertinib), a last-chance drug produced by AstraZeneca that can lead to an “unprecedented” reduction in lung cancer tumours is now available on the NHS thanks to the newly updated Cancer Drugs Fund rules which allow a promising drug to be used while still in trial evaluation. The once-a-day tablet will be available immediately for…